2026 NPPES data Hematology & Oncology Physician NPI 1114138534 MEDICAL ONCOLOGIST
Verify on CMS →

CARMEN CALFA, MEDICAL ONCOLOGIST

Hematology & Oncology Physician in HOLLYWOOD, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
193
Medicare Part D claims · 70 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
94.9927/100
▲ 12 pts above national avg 83.1 · [object Object]
Industry payments
$208.97
9 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: CARMEN CALFA, MEDICAL ONCOLOGIST is a Hematology & Oncology Physician ([object Object]) practicing in HOLLYWOOD, Florida with a Medicare Part D prescribing footprint of 193 claims across 70 beneficiaries — 6% brand-name prescribing . Their CMS MIPS Final Score of 94.9927/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $208.97 across 9 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: CARMEN CALFA, MEDICAL ONCOLOGIST reported a CMS MIPS final score of 94.9927 out of 100, above the 83.1 national average, and filed 193 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

CARMEN CALFA, MEDICAL ONCOLOGIST practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

CARMEN CALFA, MEDICAL ONCOLOGIST at a glance

High performer (top quartile)

NPI registry status

Active

Issued 05/25/2007

NPI 1114138534

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

193 77% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

94.9927/100 11.892700000000005% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Florida

How Hematology & Oncology Physician compares to other specialties among Florida providers

Florida providers

Hematology & Oncology Physician share within Florida

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Florida

Medicare quality performance — MIPS

CARMEN CALFA, MEDICAL ONCOLOGIST's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
94.9927/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 94.9927/100 vs national avg 83.1

0%100%National avg83%95%
MIPS final score (Hematology & Oncology Physician) — 94.9927/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CARMEN CALFA, MEDICAL ONCOLOGIST is a Hematology & Oncology Physician provider practicing in HOLLYWOOD, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MEDICAL ONCOLOGIST. NPI: 1114138534. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

CARMEN CALFA, MEDICAL ONCOLOGIST appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MEDICAL ONCOLOGIST credentials at 3700 JOHNSON ST, HOLLYWOOD, FL, 33021, with a listed phone of (954) 265-6990. NPI 1114138534 was issued on 05/25/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CALFA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 193 prescription claims written by this provider, covering 70 Medicare beneficiaries and totaling roughly $109K in drug spend, split 6% brand-name and 94% generic by claim count, with an opioid prescribing rate of 14.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.9927/100 for the 2023 performance year (Quality 90.8958), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3700 JOHNSON ST
HOLLYWOOD, FL 33021

Provider Details

NPI 1114138534
Specialty Hematology & Oncology Physician
Credentials MEDICAL ONCOLOGIST
Gender Female
NPI Issued 05/25/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

94.9927
Final Score
Avg: 83.1
90.8958
Quality
100
Promoting Interoperability

Reporting: Individual

Hospital and facility affiliations

Facilities where CARMEN CALFA, MEDICAL ONCOLOGIST bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNIVERSITY OF MIAMI
MIAMI, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CARMEN CALFA, MEDICAL ONCOLOGIST. Source: openpaymentsdata.cms.gov.

Total received

$209

Largest payer

Merck Sharp & Dohme LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to CARMEN CALFA, MEDICAL ONCOLOGIST. To verify CARMEN CALFA, MEDICAL ONCOLOGIST's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

CARMEN CALFA, MEDICAL ONCOLOGIST — brand share 6.0%
Specialty average (est.)

6% brand-name claims vs 94% generic, on 193 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

193
Total Claims
$109K
Total Drug Cost
70
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
305
Total Day Supply
8,199
Brand vs Generic
6% brand / 94% generic
Brand Drug Cost
$106K
Generic Drug Cost
$3K
Opioid Claims
28 (14.5% rate)

Patient Demographics

Average Patient Age
71.2 years
Avg HCC Risk Score
1.99

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Letrozole
27
Zolpidem Tartrate
23
Tramadol Hcl
21
Ibandronate Sodium
16
Alprazolam
12
Temazepam
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How CARMEN CALFA, MEDICAL ONCOLOGIST fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

CARMEN CALFA, MEDICAL ONCOLOGIST's 193 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as CALFA.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is CARMEN CALFA, MEDICAL ONCOLOGIST's specialty?
CARMEN CALFA, MEDICAL ONCOLOGIST specializes in Hematology & Oncology Physician and practices in HOLLYWOOD, Florida. Credentials: MEDICAL ONCOLOGIST.
How much does CARMEN CALFA, MEDICAL ONCOLOGIST prescribe under Medicare Part D?
In 2023, CARMEN CALFA, MEDICAL ONCOLOGIST wrote 193 Medicare Part D claims totaling $109K in drug costs for 70 beneficiaries.
What is CARMEN CALFA, MEDICAL ONCOLOGIST's Medicare quality score?
CARMEN CALFA, MEDICAL ONCOLOGIST has a CMS MIPS Final Score of 94.9927/100 (Quality: 90.8958). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is CARMEN CALFA, MEDICAL ONCOLOGIST located?
CARMEN CALFA, MEDICAL ONCOLOGIST is located at 3700 JOHNSON ST, HOLLYWOOD, FL, 33021. Phone: (954) 265-6990.
What is CARMEN CALFA, MEDICAL ONCOLOGIST's NPI number?
CARMEN CALFA, MEDICAL ONCOLOGIST's National Provider Identifier (NPI) is 1114138534, issued on 05/25/2007.
Does CARMEN CALFA, MEDICAL ONCOLOGIST prescribe more brand-name or generic drugs?
CARMEN CALFA, MEDICAL ONCOLOGIST's prescribing is 6% brand-name and 94% generic drugs by claim count, with $106K in brand drug costs.
Does CARMEN CALFA, MEDICAL ONCOLOGIST prescribe opioids?
Yes, CARMEN CALFA, MEDICAL ONCOLOGIST had 28 opioid claims in 2023 with an opioid prescribing rate of 14.5%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does CARMEN CALFA, MEDICAL ONCOLOGIST prescribe most often?
Based on 2023 Medicare Part D data, CARMEN CALFA, MEDICAL ONCOLOGIST's most frequently prescribed drugs include Letrozole, Zolpidem Tartrate, Tramadol Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CARMEN CALFA, MEDICAL ONCOLOGIST accept Medicare?
CARMEN CALFA, MEDICAL ONCOLOGIST appears in CMS Medicare data with 193 Part D claims and 70 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CARMEN CALFA, MEDICAL ONCOLOGIST's credentials?
CARMEN CALFA, MEDICAL ONCOLOGIST's NPI is 1114138534 with credentials MEDICAL ONCOLOGIST. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology